Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.
Yael N KusneHeidi E KosiorekMatthew R BurasPatricia M VeronaKyle E CoppolaKelley A RoneCurtiss B CookNina J KarlinPublished in: Future science OA (2021)
DM did not adversely affect survival of patients with NET. NET and its treatment did not affect glycemic control.